Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07653971 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ZVS101e in Patients With Bietti's Crystalline Dystrophy

Study acronym: ZVS101e-BCD
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jul 30, 2026 to Sep 30, 2026
    • Publications: 2 to 4
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the safety and early effectiveness of ZVS101e in patients with Bietti crystalline dystrophy who meet the eligibility criteria for treatment under the translational application program in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. Participants will: undergo screening and baseline assessments to confirm eligibility; receive a single subretinal injection of ZVS101e in the study eye; complete follow-up visits over 4 weeks after treatment for safety monitoring and assessment of early effectiveness.
Trial Details
NCT Number NCT07653971
Lead Sponsor Chigenovo Co., Ltd
Conditions
(from sponsor)		 Bietti's Crystalline Dystrophy, Bietti Crystalline Corneoretinal Dystrophy
Related terms Bietti Crystalline Dystrophy
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov